These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers. Corrigan DO; Corrigan OI; Healy AM Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654 [TBL] [Abstract][Full Text] [Related]
4. Unilateral fixed dilated pupil in an infant after inhalation of nebulized ipratropium bromide. Woelfle J; Zielen S; Lentze MJ J Pediatr; 2000 Mar; 136(3):423-4. PubMed ID: 10700712 [No Abstract] [Full Text] [Related]
9. A benign cause for a unilateral dilated pupil in a critical care patient. Krovvidi HP; Thillaivasan A Eur J Anaesthesiol; 2008 Aug; 25(8):692-3. PubMed ID: 18339219 [No Abstract] [Full Text] [Related]
11. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. Sapci T; Yazici S; Evcimik MF; Bozkurt Z; Karavus A; Ugurlu B; Ozkurt E Rhinology; 2008 Mar; 46(1):45-51. PubMed ID: 18444492 [TBL] [Abstract][Full Text] [Related]
12. [Dihydroergotamine as a nasal spray in the therapy of migraine attacks. Efficacy and tolerance]. Jenzer G; Bremgartner MF Schweiz Rundsch Med Prax; 1990 Aug; 79(31-32):914-7. PubMed ID: 2203127 [TBL] [Abstract][Full Text] [Related]
13. Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea. Borum S; Becker B; Mygind N; Borum P Rhinology; 1996 Dec; 34(4):198-200. PubMed ID: 9050095 [TBL] [Abstract][Full Text] [Related]
14. A new method of drug application to the nasal passage. Mackenzie I Anaesthesia; 1998 Mar; 53(3):309-10. PubMed ID: 9613282 [No Abstract] [Full Text] [Related]
15. [Asynchronous double-sided angle-closure glaucoma--a condition in an ipratropium/terbutaline treated patient under artificial ventilation]. Rasmussen H; Berger A Ugeskr Laeger; 1994 Nov; 156(48):7235-6. PubMed ID: 7817438 [TBL] [Abstract][Full Text] [Related]
16. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients. Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272 [TBL] [Abstract][Full Text] [Related]
17. Nasal airway resistance after decongestion with a nasal spray or a bellows device. Jessen M; Ivarsson A; Malm L Rhinology; 1996 Mar; 34(1):28-31. PubMed ID: 8739865 [TBL] [Abstract][Full Text] [Related]
18. Accelerated Stability Assessment of Extemporaneously Compounded Amiloride Nasal Spray. Sayre CL; Renninger B; Reaves-Mckee T; Imhoff A; Gali C; Thomas C; Patel N; Battaglia M; Davies S; Yellepeddi VK Int J Pharm Compd; 2024; 28(3):246-248. PubMed ID: 38768504 [TBL] [Abstract][Full Text] [Related]
19. New ipratropium formulation to decrease nebulization time. Majoral C; Vecellio L; Grimbert D; de Monte M; le Guellec C; Ingremeau V; Minois C; Cordeau E; Paintaud G; Steinberg A; Diot P Respir Med; 2007 Feb; 101(2):237-45. PubMed ID: 16854578 [TBL] [Abstract][Full Text] [Related]
20. Latest advances in nasal drug-delivery technology. Bommer R Med Device Technol; 1999 May; 10(4):22-8. PubMed ID: 10539106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]